Our systematic review also demonstrates the rapid evolution of targeted genetic testing for MMIHS: the first report of ACTG2-associated MMIHS was published in 2014 [3], with subsequent publications detailing new pathogenic mutations and increased rates of prenatal diagnosis of MMIHS. Here, ACTG2 is linked to megacystis-microcolon-intestinal hypoperistalsis syndrome 1.